Sleep aids for menopause compared: what the evidence says

What are the best sleep aids for menopause?

The best-supported option for menopause insomnia is CBT-I, cognitive behavioural therapy for insomnia, not a pill. Among the seven interventions in the pooled MsFLASH analysis, CBT-I produced the largest improvement in insomnia scores.

The table gathers what four sources say: the AASM 2017 pharmacologic guideline, the AGS Beers Criteria 2023, the ACP 2016 guideline and the trials named in each row. All rows were checked on 2026-10-26. Sources grade evidence differently, so the “what the source says” column quotes each one.

Option	What the source says	Typical effect on sleep	Main risk at 65 and over	Source
CBT-I	ACP: first treatment for all adults with chronic insomnia (strong, moderate-quality evidence)	-5.2 Insomnia Severity Index (ISI) points vs control in women with hot flashes	No age warning	ACP 2016; MsFLASH pooled 2018
Oral estradiol (hormone therapy)	Menopause Society 2022: most effective treatment for hot flashes; not a sleep drug	Small ISI gain at 0.5 mg a day, similar to exercise and yoga	Starting after 60 or more than 10 years past menopause has a less favourable benefit-risk balance; continuing needs an individual assessment	NAMS 2022; MsFLASH pooled 2018
Melatonin	AASM: suggests not using it for chronic insomnia (weak)	7.06 minutes faster to fall asleep; 8.25 minutes more total sleep	No age-specific finding	AASM 2017; PLoS One 2013
Magnesium	2026 review: low to very low certainty; not supported as routine treatment	Inconsistent across trials; modest gains on some self-reported measures	Not assessed by age	J Diet Suppl 2026
Omega-3 (1.8 g/day)	MsFLASH: no improvement	None	Not assessed by age	MsFLASH pooled 2018
Valerian, tryptophan	AASM: suggests not using them (weak)	No consistent clinically meaningful benefit	Not assessed by age	AASM 2017
Diphenhydramine, doxylamine (OTC antihistamines)	AASM: suggests not using diphenhydramine (weak). Beers: avoid (strong, moderate)	Tolerance develops when used as a sleep aid (Beers)	Strongly anticholinergic; clearance falls with age	AASM 2017; Beers 2023
Zolpidem, eszopiclone, zaleplon (Z-drugs)	AASM: suggests using them for chronic insomnia (weak). Beers: avoid (strong, moderate)	Quantified in the AASM review	Adverse events similar to benzodiazepines in older adults	AASM 2017; Beers 2023
Temazepam, triazolam (benzodiazepines)	AASM: suggests using them (weak). Beers: avoid (strong, moderate)	Quantified in the AASM review	Cognitive impairment, delirium, falls, fractures	AASM 2017; Beers 2023

“Weak” in an AASM recommendation means lower certainty, not that the treatment fails. The AASM guideline covers chronic insomnia in adults in general, not menopause specifically.

What is the best over-the-counter sleep aid for menopause?

No over-the-counter sleep aid has menopause-specific trial support. The two common types carry different cautions.

Antihistamine sleep aids contain diphenhydramine or doxylamine. The AASM suggests clinicians not use diphenhydramine for chronic insomnia (weak). The Beers Criteria go further for adults 65 and older: avoid first-generation antihistamines, because they are highly anticholinergic, clearance falls with age, and tolerance develops when they are used as a hypnotic. “Avoid” is a prompt to review the choice with your clinician or pharmacist, not an absolute ban.

Melatonin is the other common product. In the UK it is prescription-only; elsewhere it is sold as a supplement, so doses on the label vary. Its measured effect is small, as the next section shows. Older readers can see melatonin dose and timing for older adults.

Does melatonin work for menopause sleep problems?

Melatonin makes a small average difference to sleep: about 7 minutes faster to fall asleep in a pooled analysis of adults and children with primary sleep disorders.

The 2013 meta-analysis pooled 19 trials with 1,683 people. Sleep latency fell by 7.06 minutes (95% CI 4.37 to 9.75) and total sleep time rose by 8.25 minutes (95% CI 1.74 to 14.75). The authors said the effect did not fade with continued use and that the benefit was smaller than other drugs for insomnia.

In practice: if you take 45 minutes to fall asleep and melatonin matches the average trial result, you fall asleep in about 38 minutes (45 - 7.06). Individual response varies. The AASM, using its own review, suggests against melatonin for chronic insomnia.

Do natural sleep aids work for menopause?

Natural sleep aids have weak evidence: omega-3 did not help, the AASM suggests against valerian and tryptophan, and magnesium evidence is low certainty.

• Omega-3. In the MsFLASH pooled analysis, 1.8 g a day did not improve insomnia symptoms (546 women across four trials, 2018).
• Valerian and tryptophan. The AASM suggests clinicians not use either one for sleep onset or maintenance insomnia (weak), citing no consistent clinically meaningful benefit.
• Magnesium. A 2026 systematic review of 12 randomized trials found inconsistent results and low to very low certainty. It concluded that oral magnesium is not supported as a routine insomnia treatment, with modest gains on some self-reported measures in some adults. Nobody can yet say who benefits. Our magnesium for sleep review goes through the trials.
• Melatonin. See the section above.

For a graded list of other options, see natural remedies for menopause sleep problems. A pharmacist can check any supplement against your other medicines.

Do hormone therapy and prescription options help menopause sleep?

Hormone therapy helps sleep mainly by treating hot flashes, and its sleep effect in trials is small compared with CBT-I. Our HRT and sleep guide breaks the trials down by symptom.

In the MsFLASH pooled analysis, oral 17-beta-estradiol 0.5 mg a day gave a small drop in ISI, comparable to escitalopram and yoga, against -5.2 for CBT-I. The same study enrolled only women with at least 14 bothersome hot flashes a week. The Menopause Society’s 2022 statement says hormone therapy is the most effective treatment for hot flashes and is favourable for most women under 60 or within 10 years of menopause without contraindications. Starting it later has a less favourable benefit-risk balance because of absolute risks of heart disease, stroke, blood clots and dementia, and continuing treatment calls for an individual assessment.

Prescription sleeping pills are a separate category. The AASM suggests several of them for chronic insomnia (all weak): suvorexant, eszopiclone, zaleplon, zolpidem, triazolam, temazepam, ramelteon and doxepin. It suggests against trazodone. For adults 65 and older, Beers advises avoiding benzodiazepines and Z-drugs. The ACP says to consider medicines only after CBT-I alone has failed, and only for the short term. Low-dose doxepin for sleep is covered separately.

What should you try before buying a sleep aid?

Try CBT-I first, because both ACP guidance and the menopause trial data put it ahead of pills.

• CBT-I. The ACP guideline recommends it as the initial treatment for all adults with chronic insomnia (strong recommendation). In the first MsFLASH telephone trial of 106 women, our perimenopause insomnia guide reports ISI fell 9.9 points with CBT-I against 4.7 with education. The free CBT-i Coach app is one way to start.
• Flushes waking you. Treating the hot flashes may help the sleep. Read why hot flashes are worse at night for the options and their trial effects.
• 3am waking. Our guide to waking at 3am covers a back-to-sleep routine drawn from CBT-I methods.
• Medicines you already take. Ask a pharmacist whether any of them disturb sleep before adding another.

When should you see a doctor about sleep in menopause?

See a clinician if poor sleep lasts several weeks, or comes with loud snoring, gasping, low mood or new symptoms.

These can point to sleep apnoea, depression, thyroid problems or medicine effects, which a sleep aid will not fix. Sleeping pills, antihistamines and alcohol should never be combined. For more on sleep after 40, see the Sleep After 40 guides.

How to read this comparison

No trial put all these options against each other, and the sources use different grading systems, so the table lines up each source’s own verdict.

The CBT-I and estradiol figures come from women with at least 14 bothersome hot flashes a week and an ISI of 12 or more. The melatonin figure covers adults and children with primary sleep disorders. Beers applies to people 65 and older. Magnesium safety limits and fezolinetant are not rated here. Sources were checked on 2026-10-26.